CCA
OPTR

Catalyst Capital Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Catalyst Capital Advisors’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-20,000
Closed -$252K – 365
2013
Q3 		$252K Buy
20,000
+10,000
+100% +$133K 0.14% 210
2013
Q2 		$145K Buy
+10,000
New +$146K 0.11% 194

Catalyst Capital Advisors's OPTR Position: Q4 2013 in Review

Catalyst Capital Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 20,000 shares — an estimated $252K sold.

Catalyst Capital Advisors first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $252K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Catalyst Capital Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Catalyst Capital Advisors sold 20,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $252K.
  • Catalyst Capital Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Catalyst Capital Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $252K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Catalyst Capital Advisors's 13F filing for Q4 2013, filed 13 Feb 2014.